MWM
EW icon

Maridea Wealth Management’s Edwards Lifesciences EW Stock Holding History

Maridea Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
22,687
+1,701
+8% +$142K 0.22% 112
2026
Q1 		$1.68M Buy
20,986
+4,564
+28% +$376K 0.24% 103
2025
Q4 		$1.4M Buy
16,422
+4,352
+36% +$357K 0.21% 122
2025
Q3 		$909K Buy
+12,070
New +$943K 0.14% 150

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Maridea Wealth Management's EW Position: Q2 2026 in Review

Maridea Wealth Management increased its Edwards Lifesciences (EW) stake by 8.1% in Q2 2026, buying an estimated $142K and bringing the position to 22,687 shares worth $2.05M. The position accounts for 0.22% of the portfolio, ranked #112.

Maridea Wealth Management first reported a position in EW in Q3 2025 and has held it in 4 quarters since. 1,335 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Maridea Wealth Management held 22,687 shares of Edwards Lifesciences worth $2.05M as of Q2 2026.
  • Maridea Wealth Management bought 1,701 Edwards Lifesciences shares in Q2 2026, an estimated $142K.
  • Edwards Lifesciences made up 0.22% of Maridea Wealth Management's portfolio in Q2 2026, its #112 holding.
  • Maridea Wealth Management first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • 1,335 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Maridea Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.